% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • ryandward ryandward Nov 10, 2011 2:42 PM Flag

    Fickle price movements

    I'm all for volatility when needed, but I wish I understood the counter-analysis for positive results in a study for one stock dragging down another.

    Seriously, so trial for types 2/3 are going well and that is great. But they are a ways away from FDA filing, even further from FDA approval, even further from reimbursement agreements with companies, even further from actually going on market, and even further from getting doctors to prescribe it.

    I mean is there any doubt that Incivek is still well over 50% market into 2014? The FDA doesn't move quickly and there are studies that aren't even complete. This is a long process. I'll take the bird in the hand over 2 in the bush here.

    Also, don't doctors like to prescribe the IV because they get paid for the IV administration, whereas an oral from would cut into doctor's wallets. I know we don't like to think this way, but it is an issue.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
88.84-0.28(-0.31%)Sep 28 4:00 PMEDT